ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

NCI’s Frei & Freireich era Lauded As Researchers Receive First NIH Distinguished Alumni Award

September 14, 1990

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

June 22, 2007

Three Studies Demonstrate Oncotype DX Test Effectiveness

March 30, 2012

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

May 2, 2014

Marvin Schneiderman To Retire March 1

February 8, 1980

In Brief: Connell Is President of Komen Foundation; Ravikumar Moves to New Jersey Cancer Inst.

May 13, 1994